ArticleNPJ precision oncology2025
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients.
Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- An agentic framework for autonomous scientific discovery in cancer pathology.Nature medicine · 2026Article
- Eosinophils in solid cancers: sentinels, predictors, and therapeutic allies.Journal of experimental & clinical cancer research : CR · 2026Review
- Comprehensive insights into the roles of eosinophils in the mucosal immunity of gastrointestinal tract: defenders, destructors, and modulators.Frontiers in immunology · 2026Review
- Human eosinophils exert antitumorigenic effects on chordoma.Chinese neurosurgical journal · 2025Article
- Inflammatory profiles of transdiagnostic symptom dimensions in healthy females.Brain, behavior, & immunity - health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The immune microenvironment of colorectal cancer is a major component of the disease and influences not only tumor progression and patient outcome but also therapy response. Expanding on existing studies which have explored the prognostic value of the adaptive immune response with lymphocytes, our study integrates innate immune cells, specifically eosinophils, in a combined analysis. To evaluate the prognostic significance of eosinophils within the context of lymphocyte infiltration, we analyzed a large collective of 1625 colorectal cancer cases from four different centers. For this purpose, we develop an automatic deep learning pipeline for quantification of these immune cells directly from hematoxylin and eosin-stained whole slide images. Our analysis shows eosinophils in the tumor front (EosF) as independent prognostic factor (HR = 0.70, 95%CI = 0.55 - 0.90, p = 0.005), particularly also in microsatellite instability (MSI) cases (HR = 0.32, 95%CI = 0.14 - 0.74, p = 0.008). Moreover, EosF and intraepithelial lymphocytes (IELs) counts are statistically independent and provide additive prognostic information (EosF: HR = 0.71, 95%CI = 0.55 - 0.90, p = 0.005, IELs HR = 0.59, 95%CI = 0.35 - 0.99, p = 0.047). Our study demonstrates that eosinophils are an independent prognostic factor, which can be automatically quantified, underscoring its high potential for translation to a diagnostic biomarker. Moreover, our work could pave the way towards an integrated immune score directly from hematoxylin and eosin-stained sections.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.